biote Corp. operates in medical practice-building business within the hormone optimization space.
$1.06+1.92%
报价 2026-11-06
市值
$46.8M
EV
$186.5M
PE (TTM)
3.8x
预期 PE (FY2026)
3.8x
52 周区间距高点 -62.8%
$1.03$2.85
筛选结果
pipeline · 2026-11-06Filter✗ 高增长✗ Cheap✗ GARP
market cap below $300M floor
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| BTMDHaymaker Acquisition Corp. III | $46.8M | +1.9% | -0.5% | 70.1% | 3.8x | 5.0x | 1.2x | |
| VORVor Biopharma Inc. | $1.08B | +6.5% | +110.0% | 0% | – | 2.3x | – | |
| ANIKAnika Therapeutics, Inc. | $194.7M | -24.7% | +6.8% | 62.2% | – | 82.9x | 427.8x | |
| JYNTThe Joint Corp. | $96.9M | -7.1% | +12.1% | 76.6% | 42.5x | 92.6x | 283.6x | |
| INOInovio Pharmaceuticals, Inc. | $83.9M | -16.2% | +10800.0% | 0% | – | – | – | |
| LUCDLucid Diagnostics Inc. | $76M | +2.0% | +60.9% | -25.8% | – | – | – | |
| SPROSpero Therapeutics, Inc. | $60M | +1.0% | -96.9% | 100% | 9.7x | 3.9x | 4.0x | |
| MCRBSeres Therapeutics, Inc. | $19.7M | -5.3% | +133.3% | -20.9% | – | – | – | |
| ABOSAcumen Pharmaceuticals, Inc. | $16.2M | +4.5% | -100.0% | 0% | – | – | – | |
| 同行中位数 | – | – | +36.5% | 0% | 26.1x | 43.4x | 283.6x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
暂无季度数据（首次研究运行后填充）。